Noom to offer GLP-1 drug through new weight loss program
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149. The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk's blockbuster obesity and diabetes drugs Wegovy and Ozempic. Noom has offered...